Home / Medical Devices / Artificial Pancreas Device Systems Market By Type (Threshold Suspend Device System, Control-to-Range (CTR) System, Control-to-Target (CTT) System) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Artificial Pancreas Device Systems Market By Type (Threshold Suspend Device System, Control-to-Range (CTR) System, Control-to-Target (CTT) System) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: May 2016 | Report Code: 57854-05-16

This report on global artificial pancreas device systems (APDS) studies the overall market scenario, the ongoing trends, future commercial prospects and the competition in the artificial pancreas device systems market. For the purpose of this study, the global artificial pancreas device systems market is studied for device type and geographical distribution. This study estimates the future prospects of the APDS, post introduction of certain target devices in the diabetes market. It is to be noted that the APDS thus described do not involve biomaterial, synthetic or artificial tissue or organs and bionic substitutes.

Based on device types, the global artificial pancreas device systems market is categorized into threshold suspended device systems, control-to-range (CTR) systems, control-to-target (CTT) systems segments. The market estimates in terms of revenue forecast for each of these segments since their product launch until the year 2022 are provided in this study, along with their respective CAGRs for the corresponding periods through 2022.

The artificial pancreas device systems market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, and Japan. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

Apart from the quantitative information, this report includes qualitative information sets such as drivers, challenges and opportunities, market inclination insights, major commercial events, device mechanism of artificial pancreas device systems, and benefits to the stakeholders in this market. This report also includes tools such as attractive investment proposition, Porter’s Five Forces model and market positioning of key players to assess the overall market competition. This report concludes with profiles of certain market players that have a foothold in the global diabetes management and consequently prospective pipeline in the artificial pancreas device systems market.

The major key players profiled in the artificial pancreas device systems market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The major players profiled in this report include Medtronic, Inc., Johnson & Johnson, Inc., Pancreum LLC, Tandem Diabetes Care, Inc., and JDRF.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Artificial Pancreas Device Systems Market, by Device Type, 2016 - 2022 (USD Million)
2.2 Artificial Pancreas Device Systems Market Share, by Geography, 2022 (Value %)

Chapter 3 Artificial Pancreas Device Systems: Market Dynamics and Outlook
3.1 Introduction and Key Statistics
3.2 Artificial Pancreas Device System: Mechanism
3.3 Market Inclination Insights
3.4 Major Commercial Events
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Growing Evolution and Success of Continuous Glucose Monitors
3.5.1.2 Large Diabetes Management Market
3.5.2 Challenges
3.5.2.1 Creating Quick Acting Insulin and Glucagon Formula
3.5.2.2 Regulatory Hurdles and Cost Constraints
3.5.3 Opportunities
3.5.3.1 Involvement of Inhaled Insulin in APDS
3.5.3.2 Development of Next Generation Glucose Sensors
3.5.3.3 Intensive Investment in R&D Efforts
3.6 Benefits for Market Stakeholders
3.7 Porter's Five Forces Model
3.8 Attractive Investment Proposition
3.9 Market Positioning of Key Manufacturers

Chapter 4 Global Artificial Pancreas Device Systems Market, by Device Type
4.1 Preface
4.2 Threshold Suspend Device System
4.3 Control-to-Range (CTR) Systems
4.4 Control-to-Target (CTT) Systems

Chapter 5 Global Artificial Pancreas Device System Market, By Geography
5.1 Preface
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Medtronic, Inc.
6.1.1 Medtronic, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.3 Pancreum LLC
6.3.1 Pancreum LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.4 Tandem Diabetes Care, Inc.
6.4.1 Tandem Diabetes Care, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.5 JDRF
6.5.1 JDRF: Organizational Snapshot (Organization Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)

List of Figures

FIG. 1 Artificial Pancreas Device Systems Market, by Device Type, 2016 - 2022 (USD Million)
FIG. 2 Global Artificial Pancreas Device Systems Market Share, by Geography, 2022 (Value %)
FIG. 3 Porter's Five Forces Model: Global Artificial Pancreas Device System Market
FIG. 4 Attractive Investment Proposition:Global Artificial Pancreas Device SystemsMarket, 2015
FIG. 5 Global Threshold Suspend Device Systems Market Projections, 2015 – 2022 (USD Mn)
FIG. 6 Global Control-to-Range (CTR) Systems Market Projections, 2016 - 2022 (USD Mn)
FIG. 7 Global Control-to-Target (CTT) Systems Market Projections, 2018 – 2022 (USD Mn)
FIG. 8 Latin America Artificial Pancreas Device Systems Market Projections, 2015 – 2022 (USD Mn)
FIG. 9 Middle East and Africa Artificial Pancreas Device Systems Market Projections, 2015 – 2022 (USD Mn)

List of Tables

TABLE 1 Global Artificial Pancreas Device Systems Market Projections, by Device Type,2015 – 2022 (USD Mn)
TABLE 2 Global Artificial Pancreas Device Systems Market Projections, by Geography, 2016 – 2022 (USD Mn)
TABLE 3 North America Artificial Pancreas Device Systems Market Projections, by Country, 2016 – 2022 (USD Mn)
TABLE 4 Europe Artificial Pancreas Device Systems Market Projections, by Country, 2016 – 2022 (USD Mn)
TABLE 5 Asia Pacific Artificial Pancreas Device System Market Projections, by Country, 2016 – 2022 (USD Mn)
TABLE 6 Medtronic, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 7 Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 8 Pancreum LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 9 Tandem Diabetes Care, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 10 JDRF: Organizational Snapshot (Organization Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)

Type of Device Segmentation Investigation

Based on the type of devices the global artificial pancreas device systems market is segmented as follows:

  • Threshold Suspend Device System
  • Control-to-Range (CTR) System
  • Control-to-Target (CTT) System

The concept of artificial pancreas has eventually evolved into a mega project over these years that involve some of the biggest names in the diabetes management device market. The mission to develop a fully automated artificial pancreas system has already moved to its later stage and the products are close to commercialization. According to World Health Organization (WHO), As of 2013, 382 Mn(or 8.3% adults) people lived with diabetes, with 46% of the pool left undiagnosed. It is anticipated that by 2035, this patient population pool will reach 592 Mn with 55% undiagnosed individuals. The burden of diabetes is gigantic, with approximately USD 548 Bn spent on diabetes treatment and management in 2013 alone. Huge support and enthusiasm for research institutions and corporations, have witnessed a transition in this field over the last decade.

In 2015, MiniMed 530G a Medtronic’s first generation artificial pancreas device was commercialized in market and resulted in a noticeable growth in the market. By The device was based on threshold suspend technology which is a proprietary technology of Medtronic, Inc. is expected to achieve an early bird advantage in the market. Hence, during the forecast period threshold suspend device system is anticipated to be the largest segment. However, in 2018 five companies are expected to enter the market with advanced technologies based on control-to-target (CTT) system with their entry market is expected to boost with a significant growth.

Artificial Pancreas Device Systems Market

For the purpose of this study, the global artificial pancreas device systems market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

 

Artificial Pancreas Device Systems Market


The geographical segmentation of the global market for artificial pancreas device systems market comprises North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. In base year 2015, North America accounted for the largest market in the artificial pancreas device systems market due to large scale research and academic studies being conducted in U.S. for further exploring the perfect design of artificial pancreas is expected to majorly drive the North America artificial pancreas device market. The major key players are based in North America which is also considered as an added advantage. Asia Pacific and Latin America is expected to project highest growth after 2022 as the cost of artificial pancreas devices and systems are predicted to be high and most of the low income countries from these regions will be difficult to penetrate with it. However, the artificial pancreas device systems market is expected to achieve maturity by 2022 which would intensify the market competition, revamp of pricing strategies, and emphasis on geographical expansion and penetration. Thus, artificial pancreas device systems market in Asia Pacific and Latin America is expected to grow at exceptional rate after 2022.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients